152 related articles for article (PubMed ID: 38603656)
1. Latin American Consensus on the Treatment of Head and Neck Cancer.
Matos LL; Kowalski LP; Chaves ALF; de Oliveira TB; Marta GN; Curado MP; de Castro Junior G; Farias TP; Bardales GS; Cabrera MA; Capuzzo RC; de Carvalho GB; Cernea CR; Dedivitis RA; Dias FL; Estefan AM; Falco AH; Ferraris GA; Gonzalez-Motta A; Gouveia AG; Jacinto AA; Kulcsar MAV; Leite AK; Lira RB; Mak MP; De Marchi P; de Mello ES; de Matos FCM; Montero PH; de Moraes ED; de Moraes FY; Morais DCR; Poenitz FM; Poitevin A; Riveros HO; Sanabria Á; Ticona-Castro M; Vartanian JG; Viani G; Vines EF; William Junior WN; Conway D; Virani S; Brennan P;
JCO Glob Oncol; 2024 Apr; 10():e2300343. PubMed ID: 38603656
[TBL] [Abstract][Full Text] [Related]
2. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW; Bell RB; Bifulco CB; Burtness B; Gillison ML; Harrington KJ; Le QT; Lee NY; Leidner R; Lewis RL; Licitra L; Mehanna H; Mell LK; Raben A; Sikora AG; Uppaluri R; Whitworth F; Zandberg DP; Ferris RL
J Immunother Cancer; 2019 Jul; 7(1):184. PubMed ID: 31307547
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
5. Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.
Keam B; Machiels JP; Kim HR; Licitra L; Golusinski W; Gregoire V; Lee YG; Belka C; Guo Y; Rajappa SJ; Tahara M; Azrif M; Ang MK; Yang MH; Wang CH; Ng QS; Wan Zamaniah WI; Kiyota N; Babu S; Yang K; Curigliano G; Peters S; Kim TW; Yoshino T; Pentheroudakis G
ESMO Open; 2021 Dec; 6(6):100309. PubMed ID: 34844180
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).
Mañós M; Giralt J; Rueda A; Cabrera J; Martinez-Trufero J; Marruecos J; Lopez-Pousa A; Rodrigo JP; Castelo B; Martínez-Galán J; Arias F; Chaves M; Herranz JJ; Arrazubi V; Baste N; Castro A; Mesía R
Oral Oncol; 2017 Jul; 70():58-64. PubMed ID: 28427761
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).
Rueda A; Giralt J; Mañós M; Lozano A; Sistiaga A; García-Miragall E; Cacicedo J; Esteban F; Scola B; Contreras J; Ruiz A; Carral A; Sanchez-Aniceto G; Pastor M; Herranz JJ; Bernal M; Mesía R
Oral Oncol; 2017 Jul; 70():65-72. PubMed ID: 28427762
[TBL] [Abstract][Full Text] [Related]
8. International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
Liem X; de Baère T; Vivar OI; Seiwert TY; Shen C; Pápai Z; Moreno V; Takácsi-Nagy Z; Helfferich F; Thariat J; Gooi Z; Yom SS; Bossi P; Ferris RL; Hackman TG; Le Tourneau C; Rodriguez J; Hoffmann C
Head Neck; 2024 Jun; 46(6):1253-1262. PubMed ID: 38600434
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of head and neck spindle cell carcinoma.
Patel AM; Choudhry HS; Desai AD; Shah VP; Patel P; Eloy JA; Roden DF; Fang CH
Head Neck; 2023 Mar; 45(3):685-696. PubMed ID: 36584171
[TBL] [Abstract][Full Text] [Related]
10. Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide.
Arboleda LPA; de Carvalho GB; Santos-Silva AR; Fernandes GA; Vartanian JG; Conway DI; Virani S; Brennan P; Kowalski LP; Curado MP
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686681
[TBL] [Abstract][Full Text] [Related]
11. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review.
Afshari K; Sohal KS
Cancer Control; 2023; 30():10732748231185003. PubMed ID: 37328298
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
[TBL] [Abstract][Full Text] [Related]
13. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.
Koyfman SA; Ismaila N; Crook D; D'Cruz A; Rodriguez CP; Sher DJ; Silbermins D; Sturgis EM; Tsue TT; Weiss J; Yom SS; Holsinger FC
J Clin Oncol; 2019 Jul; 37(20):1753-1774. PubMed ID: 30811281
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
[TBL] [Abstract][Full Text] [Related]
15. Oncologic treatment landscape for head and neck squamous cell carcinoma : Treatment infrastructure in German-speaking countries.
Kimmeyer J; Kurzweg T; Hoffmann TK; Knecht R; Veit JA; Möckelmann N; Münscher A; Laban S
HNO; 2016 Jul; 64(7):494-500. PubMed ID: 27286727
[TBL] [Abstract][Full Text] [Related]
16. Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence.
Benson R; Mallick S; Julka PK; Rath GK
J Egypt Natl Canc Inst; 2016 Sep; 28(3):141-8. PubMed ID: 27160750
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Yoo GH; Moon J; Leblanc M; Lonardo F; Urba S; Kim H; Hanna E; Tsue T; Valentino J; Ensley J; Wolf G
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):869-74. PubMed ID: 19770418
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
19. The changing therapeutic landscape of head and neck cancer.
Cramer JD; Burtness B; Le QT; Ferris RL
Nat Rev Clin Oncol; 2019 Nov; 16(11):669-683. PubMed ID: 31189965
[TBL] [Abstract][Full Text] [Related]
20. Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck.
Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; Rath GK
Indian J Cancer; 2020 Feb; 57(Supplement):S1-S5. PubMed ID: 32167063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
